- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
And the stock is still at a really good price right now.
It's getting battered by news events, but its fundamental prospects are sound.
The downside of a short Tesla position seems to be significantly less than the upside.
The latest cuts may slow the bleeding, but won't heal the wound.
Facebook users seem to have more tolerance for interruption.